-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Dnx13oO266L0iHEj02lS2JpYjZa/w288WLL7ODvg//++Q+EH+6ae8JBo0JsJiXvn
 xyAgU2xkBLon9BuYLR2E4g==

<SEC-DOCUMENT>0001019687-03-002156.txt : 20031023
<SEC-HEADER>0001019687-03-002156.hdr.sgml : 20031023
<ACCEPTANCE-DATETIME>20031023204905
ACCESSION NUMBER:		0001019687-03-002156
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20031021
FILED AS OF DATE:		20031023

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			KING STEVEN W
		CENTRAL INDEX KEY:			0001244106

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-17085
		FILM NUMBER:		03955143

	BUSINESS ADDRESS:	
		STREET 1:		14272 FRANKLIN AVE.
		CITY:			TUSTIN
		STATE:			CA
		ZIP:			92780

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PEREGRINE PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000704562
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				953698422
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	BUSINESS ADDRESS:	
		STREET 1:		14282 FRANKLIN AVE
		CITY:			TUSTIN
		STATE:			CA
		ZIP:			92780
		BUSINESS PHONE:		7145086000

	MAIL ADDRESS:	
		STREET 1:		14282 FRANKLIN AVE
		CITY:			TUSTIN
		STATE:			CA
		ZIP:			92780

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TECHNICLONE CORP/DE/
		DATE OF NAME CHANGE:	19970924

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TECHNICLONE INTERNATIONAL CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>
    <schemaVersion>X0201</schemaVersion>

    <documentType>4</documentType><periodOfReport>2003-10-21</periodOfReport>
    <issuer>
        <issuerCik>0000704562</issuerCik>
        <issuerName>PEREGRINE PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>PPHM</issuerTradingSymbol></issuer><reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001244106</rptOwnerCik>
            <rptOwnerName>KING STEVEN W</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O PEREGRINE PHARMACEUTICALS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>14272 FRANKLIN AVENUE, SUITE 100</rptOwnerStreet2>
            <rptOwnerCity>TUSTIN</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>92780</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
            <reportingOwnerRelationship>
<isDirector>1</isDirector><isOfficer>1</isOfficer><isTenPercentOwner>0</isTenPercentOwner><isOther>0</isOther><officerTitle>President &amp; CEO</officerTitle></reportingOwnerRelationship></reportingOwner><nonDerivativeTable><nonDerivativeHolding><securityTitle><value>Common Stock</value></securityTitle><postTransactionAmounts><sharesOwnedFollowingTransaction><value>2000</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>D</value></directOrIndirectOwnership><natureOfOwnership><value/></natureOfOwnership></ownershipNature></nonDerivativeHolding></nonDerivativeTable><derivativeTable><derivativeTransaction><securityTitle><value>Non-Qualified Stock Option (right to buy)</value></securityTitle><conversionOrExercisePrice><value>2.20</value></conversionOrExercisePrice><transactionDate><value>2003-10-21</value></transactionDate><transactionCoding><transactionFormType>4</transactionFormType><transactionCode>A</transactionCode><equitySwapInvolved>0</equi
tySwapInvolved></transactionCoding><transactionAmounts><transactionShares><value>350000</value></transactionShares><transactionPricePerShare><footnoteId id="F2"/></transactionPricePerShare><transactionAcquiredDisposedCode><value>A</value></transactionAcquiredDisposedCode></transactionAmounts><exerciseDate><footnoteId id="F1"/></exerciseDate><expirationDate><value>2013-10-20</value></expirationDate><underlyingSecurity><underlyingSecurityTitle><value>Common stock</value></underlyingSecurityTitle><underlyingSecurityShares><value>350000</value></underlyingSecurityShares></underlyingSecurity><postTransactionAmounts><sharesOwnedFollowingTransaction><value>1140833</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>D</value></directOrIndirectOwnership><natureOfOwnership><value/></natureOfOwnership></ownershipNature></derivativeTransaction></derivativeTable><footnotes><footnote id="F1">One-third of total shares subject to the option are exercisable on 
the date of grant; One-third of total shares subject to the option are exercisable on October 21, 2004 and; One-third of total shares subject to the option are exercisable on October 21, 2005.</footnote><footnote id="F2">No price applies.</footnote></footnotes><remarks/><ownerSignature><signatureName>Paul J. Lytle, Power of Attorney for Steven W. King</signatureName><signatureDate>2003-10-23</signatureDate></ownerSignature></ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----